Abstract:Micronutrient (MN) deficiencies can produce a broad array of adverse health and functional outcomes. Young, preschool children and women of reproductive age in low- and middle-income countries are most affected by these deficiencies, but the true magnitude of the problems and their related disease burdens remain uncertain because of the dearth of reliable biomarker information on population MN status. The reasons for this lack of information include a limited understanding by policy makers of the importance of… Show more
“…The 2020 Global Nutrition Report stressed that a major outstanding laggard is the little notable progress in the collection, analysis and use of micronutrient deficiency data [83]. There has also been a call to action from the Micronutrient Forum in terms of increasing the availability and utilization of reliable data on population micronutrient (including vitamin D) status globally [84]. A lack of such data undermines a full understanding of the magnitude of the micronutrient deficiency problems and impedes their control programs [84].…”
Section: Discussionmentioning
confidence: 99%
“…There has also been a call to action from the Micronutrient Forum in terms of increasing the availability and utilization of reliable data on population micronutrient (including vitamin D) status globally [84]. A lack of such data undermines a full understanding of the magnitude of the micronutrient deficiency problems and impedes their control programs [84]. Thus, there is a clear need for strategic investment in quality, accessible surveillance and bio-banking systems among very many countries globally.…”
Background: Internationally, concern has been repeatedly raised about the little notable progress in the collection, analysis and use of population micronutrient status and deficiency data globally. The need for representative status and intake data for vitamin D has been highlighted as a research priority for well over a decade.
Aim and methods: A narrative review which aims to provide a summary and assessment of vitamin D nutritional status data globally. It divides the World into the Food and Agriculture Organisation’s (FAO) major regions: the Americas, Europe, Oceania, Africa, and Asia. Emphasis was placed on published data on prevalence of serum 25-hydroxyvitamin D [25(OH)D] <25/30 and <50 nmol/L (reflecting vitamin D deficiency and inadequacy, respectively) as well as vitamin D intake, where possible from nationally representative surveys.
Results: Collating data from the limited number of available representative surveys from individual countries might suggest a relatively low overall prevalence of vitamin D deficiency in South America, Oceania and North America, whereas there is more moderate prevalence in Europe and Asia, and possibly Africa. Overall, prevalence of serum 25(OH)D <25/30 and <50 nmol/L ranges from ~5% to 18% and 24% to 49%, respectively, depending on FAO World region. Usual intakes of vitamin D can also vary by FAO World region, but in general, with a few exceptions, there are very high levels of inadequacy of vitamin D intake.
Conclusions: While the burden of vitamin D deficiency and inadequacy varies by World regions and not just by UVB availability, the global burden overall translates into enormous numbers of individuals at risk.
“…The 2020 Global Nutrition Report stressed that a major outstanding laggard is the little notable progress in the collection, analysis and use of micronutrient deficiency data [83]. There has also been a call to action from the Micronutrient Forum in terms of increasing the availability and utilization of reliable data on population micronutrient (including vitamin D) status globally [84]. A lack of such data undermines a full understanding of the magnitude of the micronutrient deficiency problems and impedes their control programs [84].…”
Section: Discussionmentioning
confidence: 99%
“…There has also been a call to action from the Micronutrient Forum in terms of increasing the availability and utilization of reliable data on population micronutrient (including vitamin D) status globally [84]. A lack of such data undermines a full understanding of the magnitude of the micronutrient deficiency problems and impedes their control programs [84]. Thus, there is a clear need for strategic investment in quality, accessible surveillance and bio-banking systems among very many countries globally.…”
Background: Internationally, concern has been repeatedly raised about the little notable progress in the collection, analysis and use of population micronutrient status and deficiency data globally. The need for representative status and intake data for vitamin D has been highlighted as a research priority for well over a decade.
Aim and methods: A narrative review which aims to provide a summary and assessment of vitamin D nutritional status data globally. It divides the World into the Food and Agriculture Organisation’s (FAO) major regions: the Americas, Europe, Oceania, Africa, and Asia. Emphasis was placed on published data on prevalence of serum 25-hydroxyvitamin D [25(OH)D] <25/30 and <50 nmol/L (reflecting vitamin D deficiency and inadequacy, respectively) as well as vitamin D intake, where possible from nationally representative surveys.
Results: Collating data from the limited number of available representative surveys from individual countries might suggest a relatively low overall prevalence of vitamin D deficiency in South America, Oceania and North America, whereas there is more moderate prevalence in Europe and Asia, and possibly Africa. Overall, prevalence of serum 25(OH)D <25/30 and <50 nmol/L ranges from ~5% to 18% and 24% to 49%, respectively, depending on FAO World region. Usual intakes of vitamin D can also vary by FAO World region, but in general, with a few exceptions, there are very high levels of inadequacy of vitamin D intake.
Conclusions: While the burden of vitamin D deficiency and inadequacy varies by World regions and not just by UVB availability, the global burden overall translates into enormous numbers of individuals at risk.
“…Specifically, a recent initiative to develop a strategic plan to increase the availability and utilization of reliable data on population micronutrient status globally also emphasized the need for more data on folate, vitamin B-12, vitamin D, and thiamin ( 6 , 7 ), whose deficiencies may result in physical disability, sensory impairments, restricted physical growth, impaired neurocognitive development, or death ( 21–23 , 91–93 ). Other micronutrients such as riboflavin, niacin, and pyridoxine and mineral elements such as calcium and selenium may be equally important for public health, but information about them is even more limited because of the scarcity of population status data ( 7 ). Without population-level assessments of these micronutrient deficiencies, we will remain uncertain about their public health impact and thus fail to address and prevent potential deficiencies and associated health consequences.…”
Section: Discussionmentioning
confidence: 99%
“…The Global Dietary Database 2017 identified a total of 1220 dietary surveys, but only 113 surveys assessed dietary iron intake, 78 surveys assessed dietary zinc, and <20 surveys each assessed vitamin A (including vitamin A supplement intake) and iodine intake ( 51 ). Thus, there is a scarcity of information on population micronutrient status based on reliable biomarkers and dietary intake ( 7 ), and there currently is inadequate information to estimate the global prevalence of iron and zinc deficiencies reliably for the years of interest from 1990 to the present, which are modeled in the GBD Study.…”
Section: Steps Required To Estimate the Prevalence Of Micronutrient Deficiencies And Associated Disease Burdenmentioning
confidence: 99%
“…Despite the serious consequences of these deficiencies for the individual and for society, there are limited data on vitamin and mineral status of human populations from nationally representative surveys, especially in low- and middle-income countries. This lack of information hinders global, regional, and national efforts to prevent micronutrient deficiencies and their consequences ( 6 , 7 ). Information on the prevalence of micronutrient deficiencies is needed to assess the related disease burden; underpin evidence-based advocacy; and design, deliver, target, and monitor safe, effective, and sustainable intervention programs ( 8–10 ).…”
Information on the prevalence of micronutrient deficiencies is needed to determine related disease burden; underpin evidence-based advocacy; and design, deliver, and monitor safe, effective interventions. Assessing the global prevalence of deficiency requires a valid micronutrient status marker with an appropriate cutoff to define deficiency and relevant data from representative surveys across multiple locations and years. The Global Burden of Disease Study includes prevalence estimates for iodine, iron, zinc, and vitamin A deficiencies, for which recommended biomarkers and appropriate deficiency cutoffs exist. Because representative survey data are lacking, only retinol concentration is used to model vitamin A deficiency, and proxy indicators are used for the other micronutrients (goiter for iodine, hemoglobin for iron and dietary food adequacy for zinc). Because of data limitations, complex statistical modeling is required to produce current estimates, relying on assumptions and proxies that likely understate the extent of micronutrient deficiencies and the consequent global health burden.
Brief lay summary
In this review, steps needed to estimate micronutrient deficiency prevalence and related disease burdens are described; challenges are outlined using the Global Burden of Disease Study as a case study.
Purpose
To assess the effects of intervention with a daily multiple micronutrient powder (MNP) on thiamine, riboflavin, folate, and B12 status among young Laotian children.
Methods
Children (n = 1704) aged 6–23 mo, participating in a double-blind placebo-controlled randomized trial were individually randomized to receive daily either MNP (containing 0.5 mg of thiamine, 0.5 mg riboflavin, 150 μg folic acid, and 0.9 μg vitamin B12 along with 11 other micronutrients) or placebo and followed for ~ 36 weeks. In a randomly selected sub-sample of 260 children, erythrocyte thiamine diphosphate (eThDP), plasma folate and B12 concentrations, and erythrocyte glutathione reductase activation coefficient (EGRac; riboflavin biomarker) were assessed at baseline and endline.
Results
There was no treatment effect on endline eThDP concentrations (110.6 ± 8.9 nmol/L in MNP vs. 109.4 ± 8.9 nmol/L in placebo group; p = 0.924), EGRac (1.46 ± 0.3 vs. 1.49 ± 0.3; p = 0.184) and B12 concentrations (523.3 ± 24.6 pmol/L vs. 515.9 ± 24.8 pmol/L; p = 0.678). Likewise, the prevalence of thiamine, riboflavin, and B12 deficiencies did not differ significantly between the two groups. However, endline folate concentration was significantly higher in the MNP compared to the placebo group (28.2 ± 0.8 nmol/L vs 19.9 ± 0.8 nmol/L, respectively; p < 0.001), and correspondingly, the prevalence of folate deficiency was significantly lower in the MNP group (1.6% vs 17.4%; p = 0.015).
Conclusions
Compared to a placebo, daily MNP for 9 months increased only folate but not thiamine, riboflavin, or B12 status in young Laotian children.
Trial registration
The trial was registered at www.clinicaltrials.gov (NCT02428647) on April 29 2015.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.